Israel - hebreiska - Ministry of Health

bristol, myers squibb (israel) limited, israel - abatacept - תמיסה להזרקה - abatacept 125 mg/ml - abatacept - abatacept - orencia is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis. orencia may be used as monotherapy or concomitantly with disease-modifying antirheumatic drugs (dmards) other than tumor necrosis factor (tnf) antagonists.

Israel - hebreiska - Ministry of Health

j-c health care ltd - golimumab - תמיסה להזרקה - golimumab 50 mg / 0.5 ml - golimumab - golimumab - rheumatoid arthritis :simponi, in combination with methotrexate, is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis when the response to disease-modifying anti-rheumatic drug (dmard) therapy including mtx has been inadequate.psoriatic arthritis :simponi, alone or in combination with methotrexate, is indicated for the treatment of adult patients with active and progressive psoriatic arthritis when the response to previous disease-modifying anti-rheumatic drug (dmard) therapy has been inadequate.ankylosing spondylitis :simponi is indicated for the treatment of adult patients with severe active ankylosing spondylitis who have responded inadequately to conventional therapy.

Israel - hebreiska - Ministry of Health

roche pharmaceuticals (israel) ltd - tocilizumab - תרכיז להכנת תמיסה לאינפוזיה - tocilizumab 20 mg/ml - tocilizumab - tocilizumab - actemra (tocilizumab) is indicated for reducing signs and symptoms in adult patients with moderately to severely active rheumatoid arthritis who had an inadequate response to one or more dmards (disease modifying antirhematic drugs) or tnf antagonists or in whom dmards cannot be used. actemra can be used alone or in combination with methotrexate or other dmards.actemra® has been shown to reduce progression of joint damage as measured by x-ray and to improve physical function when given in combination with methotrexate. actemra® is indicated for the treatment of active systemic juvenile idiopathic arthritis in patients 2 years of age and older.

Israel - hebreiska - Ministry of Health

taro pharmaceutical industries ltd - oxycodone hydrochloride; paracetamol - טבליה - oxycodone hydrochloride 10 mg; paracetamol 325 mg - paracetamol - paracetamol - for the relief of moderate to moderately severe pain.

Israel - hebreiska - Ministry of Health

taro pharmaceutical industries ltd - oxycodone hydrochloride; paracetamol - טבליה - paracetamol 325 mg; oxycodone hydrochloride 5 mg - paracetamol, combinations with psycholeptics - paracetamol, combinations with psycholeptics - for the relief of moderate to moderately severe pain.

Israel - hebreiska - Ministry of Health

pfizer pharmaceuticals israel ltd - donepezil hydrochloride 5 mg - film coated tablets - donepezil - treatment of mild to moderately severe alzheimer's dementia.

Israel - hebreiska - Ministry of Health

pfizer pharmaceuticals israel ltd - donepezil hydrochloride 10 mg - film coated tablets - donepezil - treatment of mild to moderately severe alzheimer's dementia.

Israel - hebreiska - Ministry of Health

padagis israel pharmaceuticals ltd, israel - donepezil hydrochloride - טבליה - donepezil hydrochloride 5 mg - donepezil - donepezil - for the treatment of mild to moderately severe alzheimer's dementia

Israel - hebreiska - Ministry of Health

padagis israel pharmaceuticals ltd, israel - donepezil hydrochloride - טבליה - donepezil hydrochloride 10 mg - donepezil - donepezil - for the treatment of mild to moderately severe alzheimer's dementia

Israel - hebreiska - Ministry of Health

teva pharmaceutical industries ltd, israel - donepezil hydrochloride - טבליה - donepezil hydrochloride 5 mg - donepezil - donepezil - treatment of mild to moderately severe alzheimer's dementia.